{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:39:42Z","timestamp":1793299182715,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K01 CA237875"],"award-info":[{"award-number":["K01 CA237875"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.dld.2021.12.002","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T21:23:40Z","timestamp":1640208220000},"page":"964-972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk"],"prefix":"10.1016","volume":"54","author":[{"given":"Duaa S.","family":"Nasereldin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Launia J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2372-9489","authenticated-orcid":false,"given":"Samuel O.","family":"Antwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2021.12.002_bib0001","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.12.002_bib0002","series-title":"Cancer facts & figures 2021","year":"2021"},{"key":"10.1016\/j.dld.2021.12.002_bib0003","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/hep.27443","article-title":"Prognosis of untreated hepatocellular carcinoma","volume":"61","author":"Giannini","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.12.002_bib0004","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2016.11.020","article-title":"Incidence of hepatocellular carcinoma in all 50 United States, From 2000 through 2012","volume":"152","author":"White","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.12.002_bib0005","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1200\/JCO.2015.64.7412","article-title":"Future of hepatocellular carcinoma incidence in the United States Forecast through 2030","volume":"34","author":"Petrick","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2021.12.002_bib0006","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.002_bib0007","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2021.12.002_bib0008","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.002_bib0009","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature06882","article-title":"Human metabolic phenotype diversity and its association with diet and blood pressure","volume":"453","author":"Holmes","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.dld.2021.12.002_bib0010","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cncr.29971","article-title":"Population attributable fractions of risk factors for hepatocellular carcinoma in the United States","volume":"122","author":"Makarova-Rusher","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2021.12.002_bib0011","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.24397","article-title":"Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database","volume":"54","author":"Welzel","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.12.002_bib0012","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ijc.26338","article-title":"Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults","volume":"131","author":"Borena","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.dld.2021.12.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/9\/1\/016005","article-title":"A cross-sectional study of breath acetone based on diabetic metabolic disorders","volume":"9","author":"Li","year":"2015","journal-title":"J Breath Res"},{"key":"10.1016\/j.dld.2021.12.002_bib0014","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2217\/bmm.12.93","article-title":"Metabolic disorders: all that we know from circulating biomarkers","volume":"6","author":"Nobili","year":"2012","journal-title":"Biomark Med"},{"key":"10.1016\/j.dld.2021.12.002_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12902-019-0472-2","article-title":"Impact of metabolically healthy obesity on the risk of incident gastric cancer: a population-based cohort study","volume":"20","author":"Hashimoto","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.dld.2021.12.002_bib0016","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1158\/1055-9965.EPI-20-1262","article-title":"Effect of Metabolic Health and Obesity Phenotype on the Risk of Pancreatic Cancer: a Nationwide Population-Based Cohort Study","volume":"30","author":"Chung","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.dld.2021.12.002_bib0017","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","article-title":"Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications","volume":"1","author":"Stefan","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.dld.2021.12.002_bib0018","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1470-2045(02)00849-5","article-title":"Overweight, obesity, and cancer risk","volume":"3","author":"Bianchini","year":"2002","journal-title":"The lancet oncology"},{"key":"10.1016\/j.dld.2021.12.002_bib0019","series-title":"Cancer of the pancreas. schottenfeld and fraumeni cancer epidemiology and prevention","first-page":"611","author":"Antwi","year":"2017"},{"key":"10.1016\/j.dld.2021.12.002_bib0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/cbf.3229","article-title":"From obesity to cancer: a review on proposed mechanisms","volume":"34","author":"Tahergorabi","year":"2016","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.dld.2021.12.002_bib0021","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fphys.2015.00032","article-title":"Cardiovascular and metabolic consequences of obesity","volume":"6","author":"Head","year":"2015","journal-title":"Front Physiol"},{"key":"10.1016\/j.dld.2021.12.002_bib0022","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archinte.168.15.1609","article-title":"Identification and characterization of metabolically benign obesity in humans","volume":"168","author":"Stefan","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dld.2021.12.002_bib0023","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004)","volume":"168","author":"Wildman","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dld.2021.12.002_bib0024","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0140-6736(11)60805-2","article-title":"Global trends in body-mass index","volume":"377","author":"Stefan","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.dld.2021.12.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001988","article-title":"A nested case-control study of metabolically defined body size phenotypes and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"13","author":"Murphy","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.dld.2021.12.002_bib0026","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/ije\/dyx268","article-title":"Data Resource Profile: expansion of the Rochester Epidemiology Project medical records-linkage system (E-REP)","volume":"47","author":"Rocca","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.dld.2021.12.002_bib0027","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mayocp.2011.11.009","article-title":"Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project","volume":"87","author":"St Sauver","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.dld.2021.12.002_bib0028","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/ijc.33007","article-title":"One-carbon metabolism-related micronutrients intake and risk for hepatocellular carcinoma: a prospective cohort study","volume":"147","author":"Antwi","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.dld.2021.12.002_bib0029","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1158\/1940-6207.CAPR-19-0162","article-title":"Risk of De Novo Hepatocellular Carcinoma Following Use of Direct Acting Antiviral Medications for Treatment of Chronic Hepatitis C","volume":"12","author":"Antwi","year":"2019","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.dld.2021.12.002_bib0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/MCG.0000000000001182","article-title":"Independent and Joint Use of Statins and Metformin by Elderly Patients With Diabetes and Overall Survival Following HCC Diagnosis","volume":"54","author":"Antwi","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2021.12.002_bib0031","first-page":"63","article-title":"Braunwald's heart disease: a textbook of cardiovascular medicine","volume":"5","author":"Zipes","year":"2018","journal-title":"BMH Medical Journal-ISSN 2348\u2013392X"},{"key":"10.1016\/j.dld.2021.12.002_bib0032","series-title":"Kumar and clark's clinical medicine E-Book","author":"Feather","year":"2020"},{"key":"10.1016\/j.dld.2021.12.002_bib0033","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2337\/dc21-S002","article-title":"Classification and Diagnosis of Diabetes: standards of Medical Care in Diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2021.12.002_bib0034","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7326\/M17-3203","article-title":"Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: synopsis of the 2017 American College of Cardiology\/American Heart Association Hypertension Guideline","volume":"168","author":"Carey","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2021.12.002_bib0035","first-page":"1","article-title":"Guideline for High Blood Pressure in Adults","author":"Whelton","year":"2017","journal-title":"Am Collf Cardiol"},{"key":"10.1016\/j.dld.2021.12.002_bib0036","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.dld.2021.12.002_bib0037","first-page":"717","article-title":"Obesity: overview of an epidemic","volume":"34","author":"Mitchell","year":"2011","journal-title":"Psychiatric Clinics"},{"key":"10.1016\/j.dld.2021.12.002_bib0038","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1053\/j.gastro.2004.09.021","article-title":"Obesity and hepatocellular carcinoma","volume":"127","author":"Caldwell","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.12.002_bib0039","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/bjc.2012.492","article-title":"Metabolic syndrome and hepatocellular carcinoma risk","volume":"108","author":"Turati","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2021.12.002_bib0040","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.amjmed.2016.12.029","article-title":"Independent of cirrhosis, hepatocellular carcinoma risk is increased with diabetes and metabolic syndrome","volume":"130","author":"Kasmari","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2021.12.002_bib0041","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/hep.27014","article-title":"Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly","volume":"59","author":"Chiang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.12.002_bib0042","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/00004872-199715120-00058","article-title":"Cancer and hypertension: a potential for crosstalk?","volume":"15","author":"Hamet","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.dld.2021.12.002_bib0043","first-page":"185","article-title":"The effect of prediabetes on hepatocellular carcinoma risk: a systematic review and meta-analysis","volume":"108","author":"Xu","year":"2016","journal-title":"Minerva Med"},{"key":"10.1016\/j.dld.2021.12.002_bib0044","series-title":"Prediabetes and the risk of cancer: a meta-analysis","author":"Huang","year":"2014"},{"key":"10.1016\/j.dld.2021.12.002_bib0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cgh.2005.12.007","article-title":"The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence","volume":"4","author":"El\u2013Serag","year":"2006","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2021.12.002_bib0046","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4239\/wjd.v5.i3.372","article-title":"Diabetes and cancer: associations, mechanisms, and implications for medical practice","volume":"5","author":"Xu","year":"2014","journal-title":"World J Diabetes"},{"key":"10.1016\/j.dld.2021.12.002_bib0047","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10654-013-9806-y","article-title":"Statin use and risk of hepatocellular carcinoma","volume":"28","author":"Lai","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.dld.2021.12.002_bib0048","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1053\/j.gastro.2009.01.053","article-title":"Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes","volume":"136","author":"El\u2013Serag","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.12.002_bib0049","doi-asserted-by":"crossref","first-page":"692","DOI":"10.21037\/tlcr.2019.09.08","article-title":"Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms","volume":"8","author":"Fatehi Hassanabad","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.dld.2021.12.002_bib0050","doi-asserted-by":"crossref","first-page":"573","DOI":"10.5306\/wjco.v11.i8.573","article-title":"Statins in risk-reduction and treatment of cancer","volume":"11","author":"Barbalata","year":"2020","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.dld.2021.12.002_bib0051","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/01.STR.0000174289.34110.b0","article-title":"Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month","volume":"36","author":"Mart\u00edn-Ventura","year":"2005","journal-title":"Stroke"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821008896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821008896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:18:23Z","timestamp":1761625103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865821008896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1590865821008896"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2021.12.002","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2021.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}